Jeff Workman Email & Phone Number

Lewisville, Texas

Vice President Sales North and South America, Extremities Business UnitResponsible for approx. $40M in annual turnover between North and South American distribution networks. • Rebuilt the U.S. sales management team and expanded the marketing support efforts for the domestic market.• Built durable and efficient communication channels between Verona, Italy HQ and the U.S. HQ• Led re-organization of the Brazilian HQ and refocus on growth with improved distribution partners in the region• In response to COVID19, reimagined the Marketing/Medical Education strategy and delivery systems resulting in increased attendance, engagement and quality of product delivered.

Sammamish Wa

Creating commercialization strategies and execution plans for medical device companies at all stages of the device/therapy commercialization/adoption process. Areas of specialization include:• Market definition, sizing and growth drivers• Competitive analysis and key points of differentiation and competitive advantage/disadvantage• Strategic and tactical sales and marketing processes and measurement of key metrics for success• Sales team sizing, productivity and compensation planning

Redmond, Washington

Leading global commercialization strategy for Spiration Valve System and driving therapy adoption across broad range of geographies and health economics landscapes. • Delivered annual global sales of $13M, 14% above plan by retooling U.S. sales compensation plan driving record U.S. revenue (+16% or +$1M) and Year-Over-Year (YOY) procedure growth of 24%.• Engaged International affiliates thru field presence and clinical support in Canada, Europe, and Australia to re-invigorate sales efforts and provide dedicated Spiration Valve resources leading to new growth. Sales and marketing functions were eliminated in Redmond WA. and consolidated in Center Valley PA. HQ for Olympus Corporation Americas.

Munich, Germany

Led global commercial operations for Jena Valve Technology GmbH. Relocated to Munich, Germany and drove expansion of sales and marketing team in preparation for commercial launch of Jena Valve trans-femoral, direct aortic, and trans-apical porcine pericardial prosthesis, delivery systems, and accessories. • Delivered $10.4M in sales and YOY unit sales increase thru July of 18% in declining trans-apical market while holding average selling price erosion to -2% in declining market by expanding and training European direct sales by 5 new territories. • Grew international distribution markets by 11% with expansion into 10+ new geographies by vetting, contracting, and training multiple new stocking distributors.• Negotiated term sheet for Japanese distribution, including conduct of Japanese clinical study obtaining Pharmaceuticals and Medical Devices Agency (PMDA) approval and Shonin.

Arvada Colorado, Saluggia, Italy

Leader of the U.S. Heart Valve Business Unit of Sorin Group. Commercial P&L responsibility for the U.S. business unit with 54 direct and indirect reports. Direct reporting relationship with the U.S. Sales and Marketing, Customer Service, Contracts and Logistics. Indirect reporting relationship with Finance, Clinical Research, Regulatory Affairs. Managed Japanese business relationship with the Sorin distributor, Japan Lifeline. Voice for all three Sorin Group B.U.’s, (HV, CP, & CRM) with Executive Leadership Team in Milan as U.S. Country Leader.• Developed and hired national accounts function representing all 3 business units of Sorin Group U.S.A. leading to inclusion on multiple national purchasing/IDN agreements. • Developed and led US PMA clinical study strategy for Perceval Sutureless Aortic Bioprosthesis leading to on-time launch in US.

Arvada, Colorado And Saluggia, Italy

•Led U.S. and European direct sales organizations and managed the business relationship with our Japanese distributor Japan Lifeline (JLL).• Commercial P&L responsibility for U.S. HVBU with ~$50M in annual turnover with EBITDA growth of 324% over 5 years.• Grew total sales for the U.S. HVBU by 139% or $26M over 5 year tenure• Executed the limited launch of the Perceval S Sutureless Bovine Pericardial Heart Valve in Europe growing sales 2.7M Euros with limited sizes/accessories portfolio.•Delivering double digit EBIT growth while significantly growing the business unit investment in S&M •Slowed a -17% decline in sales mechanical heart valve sales to the market erosion rate of <5%.•Grew mitral valve repair sales at double digit rates •Led the reorganization and expansion of the U.S. Sales and Marketing teams doubling the size of the direct U.S.sales team from 4 Regional Managers and 19 Account Executives to 6 RM’s, 1 Manager of Sales Training and National Accounts and 37 Account Execs and 6 independent sales agents.•Designed and implemented a new pay for performance culture and sales compensation plan for both sales management and Account Execs that links all business elements.•Redefined the role and skill set requirements of the U.S. Marketing organization and put the appropriate leadership in place to manage the renovation and staffing of what is now a highly productive and creative marketing department.•Active member of the Heart Valve Business Unit Senior Leadership Team participating in multiple new business development analyses and due diligence projects to add new products and services to the existing sales offering and internal R&D portfolio.

Irvine, Ca.

Global general managerial responsibility for $70M vascular surgery franchise; manage staff of eight with four direct reports. Indirect reporting relationships with regional marketing and sales organizations in North America, Europe, Japan, Latin America and Asia Pacific. Cross-functional reporting relationships with R&D, Business Development, Regulatory/Clinical Affairs, Manufacturing, Quality, Finance.•Doubled Lifestent self-expanding stent and balloon expandable stent product line sales from $8M to $16M+ in 2006 with 125% achievement of sales plan in Europe and 300% sales growth in the Intercontinental region.•Delivered 110% of the Base Vascular sales plan in North America and 100% of a high growth plan for Europe (+8% in a declining market) in 2006•Defined the strategic direction of the Vascular global business, developed and executed both the strategic and operating plan.•Developed, integrated and executed the regional franchise operating plans into the global franchise operating plan. Conducted of quarterly reviews of progress to plan in the regions.•Led the LifeStent global marketing team and the global launch/marketing and sales effort or this high profile Edwards growth initiative.•Led the development of the global Vascular Franchise marketing plan and the integration of regional plans •Secured Executive Leadership Team approval to pursue partnership opportunities in the development of devices to address peripheral vascular disease needs

Cincinnati, Ohio

Ethicon Endo Surgery is a division of Johnson and Johnson and the world leader in minimally invasive surgical technologies and open surgical stapling devices with over $2B in annual sales.•Marketing Manager - Strategic Projects Developed strategic rationale and global objectives for the acquisition and integration of the Ultracision Harmonic Scalpel and 3M stapling businesses. Responsible for generating global product line forecasts, marketing plans and marketing/sales strategies and budgets as inputs to the acquisition analysis. •Marketing Manager - Mechanical Products Set line strategy, developed and implemented promotional tactics and achievement of market share goals for linear stapling product lines.•Team Marketing Manager - Access 55Developed and implemented AX55 positioning, promotion, product launch process, and forecast achievement. •Procedure Development Manager, Gynecology Planned and coordinated the direction of national and international resources to develop and/or acquire products and technologies that provide value to customers performing traditional and minimally invasive surgical procedures. •Section Manager, Dept. of Clinical Research Supervisory budgetary responsibility for four-member Clinical Research Dept. Responsibility for creating system for maintenance of department records, study data, and instrument inventory in compliance with FDA and internal Q.A. requirements.